CARROLLTON, TEXAS, UNITED STATES, November 17, 2021 — Alternative Biomedical Solutions (ABS) announced today the launch of an entirely new corporate website designed to enhance the depth of information and resources provided to customers, as well as companies newly in the market for ABS’ wide range of laboratory products and services. As the new site continues to grow, it will provide seamless access to ABS’ lab solutions and products serving a wide range of markets, consulting services, class-leading technical service and maintenance contracts, refurbishment program, lab software platforms, and CLIA-accredited reference laboratory.
ABS is ‘Essential in Labs’ and represents an integrated partner for solutions in markets where lab work is critical, and companies are either seeking to set up or optimize testing laboratories or outsource testing as effectively as possible. ABS is a partner of choice and brings decades of experience to provide reassurance to customers.
ABS is also a pioneering company, particularly leading the charge in hgh growth areas like the cannabis production market and PFAS testing. ABS’s team of experts were involved in the earliest usage of LC-MS in toxicology and developed some of the fundamental screening methods. New applications for lab testing are being developed by this team all the time, and it provides impartial consulting on solutions that are not tied to any particular manufacturer.
Joseph Coffey, Chief Operating Officer of ABS, said, “ABS continues to expand applications for a wide range of laboratory solutions, products and services and we bring unparalleled expertise to the market. Our new website will provide a better interface for all of our customers and a wide audience across areas like toxicology, physician’s offices and clinics, criminal justice, environmental testing and the cannabis market.
A leader in toxicology testing solutions, ABS is a laboratory equipment, service, and supply company. ABS provides value-added solutions to clinical laboratories, healthcare providers, pharmaceutical companies, research organizations, and other testing laboratories. ABS is a Centre Lane Partners portfolio company.